why does nobody talk about telehealth
Genuine question, and the title is the question: why does nobody talk about telehealth. Asked for potency testing on the finished preparation. They had it. I had assumed they would not. Kept the label from every vial. When the shortage status changed, having the paper trail made the conversation much shorter. Paid…
Disagree — a 503B being registered does not make its preparations equivalent to an approved product. Different regulatory category entirely.
Did they name the facility?
[removed by moderator]
That figure is the starting material purity, not the finished preparation potency. Two different tests.
I would not read the price difference as a quality signal. Most of it is the consultation model, not the vial.
Salt form matters for mass: a preparation specified as one salt and dosed as the free base gives you a different amount of peptide for the same number on the label.